海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study
- Lung Cancer
- Italy
- 2014-04-24
Not recruiting
- BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer
- Neoplasms
- Austria, Belgium, France, Ireland, Korea, Republic of, Netherlands, Spain, Sweden, Taiwan, United Kingdom
- 2014-04-22
Not recruiting
- A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Canada, France, Germany, Spain, United States
- 2014-04-17
Not Recruiting
- A multicenter, open-label, phase 2 study of S-588410 after first-line chemotherapy in patients with advanced and/or metastatic bladder cancer
- bladder cancer
- Europe, Japan
- 2014-04-07
Not recruiting
- Second Line Sorafenib After Pazopanib in Patients With RCC
- Metastatic Renal Cell Carcinoma;Metastatic Renal Cell Carcinoma;Metastatic Renal Cell Carcinoma;Metastatic Renal Cell Carcinoma
- Italy
- 2014-04-06
Not recruiting
- Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study
- Liver Disease;Liver Disease;Liver Disease
- United Kingdom
- 2014-03-25
Not Recruiting
- Clinical trial with L-asparaginase encapsulated in erythrcoytes in patients affected by metastatic pancreatic cancer after first line treatment
- Pancreatic cancer MedDRA version: 16.1 Level: LLT Classification code 10051971 Term: Pancreatic adenocarcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- France
- 2014-02-28
Not recruiting
- Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
- Metastatic Colorectal Cancer
- Argentina, Brazil, India, Peru, Russian Federation, Spain, Ukraine
- 2014-02-14
Not recruiting
- Trabectedin First Line Therapy In Unfit Sarcoma Study
- Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive;Standard Chemotherapy;Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive;Standard Chemotherapy;Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive;Standard Chemotherapy
- Italy
- 2014-02-13
Not recruiting
- GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations
- Carcinoma, Non-Small-Cell Lung
- Germany
- 2014-01-27
Not recruiting
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2014-01-19
Not Recruiting
- A randomized, evaluator-blinded, comparative study to evaluate the efficacy and safety of different injection volumes of botulinum toxin type A, Azzalure®, in the glabellar lines.
- Glabella frown lines br>MedDRA version: 16.1 Level: LLT Classification code 10052609 Term: Glabellar frown lines System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Sweden
- 2013-12-19
Not Recruiting
- Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Czech Republic, European Union, Germany, Greece, Netherlands, United Kingdom, United States
- 2013-09-02
Not recruiting
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
- Endometrial Cancer;Endometrial Cancer;Endometrial Cancer;Endometrial Cancer
- Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Czech Republic, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom, United States
- 2013-01-09
Not recruiting
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
- Colorectal Cancer Metastatic
- Austria, Belgium, Canada, China, Czech Republic, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Singapore, Spain, United Kingdom, United States
- 2011-11-24
Not recruiting
- Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
- Colorectal Cancer Metastatic
- Ireland, United States
- 2011-02-16
Not Recruiting
- Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients with Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)
- Patients with stage IV metastatic squamous non-small cell lung cancer MedDRA version: 20.0 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Germany
- 2015-08-04
Not recruiting
- Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein
- AOD Effects and Consequences
- Germany
- 2015-08-01
Not Recruiting
- A 28-week trial to determine treatment optimization with once-daily TOUJEO in combination with prandial rapid-acting insulin analogue in patients with type 1 diabetes previously uncontrolled on twice daily basal insulin as part of basal-bolus therapy
- Type 1 diabetes mellitus br>MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Belgium, Canada
- 2015-07-31
Not recruiting
- Phase II Trial of HM61713 for the Treatment of =2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
- Non Small Cell Lung Cancer;Non Small Cell Lung Cancer;Non Small Cell Lung Cancer
- Australia, Canada, Germany, Italy, Korea, Republic of, Malaysia, Philippines, Spain, Taiwan, United States
- 2015-06-22
